Cancer Immunotherapy Market to Reach USD 296.25 Billion by 2032, Driven by Advancements in Targeted Therapies

Cancer Immunotherapy Market to Reach USD 296.25 billion by 2032, Driven by Advancements in Targeted Therapies

Cancer immunotherapy is a cancer treatment that enhances the immune system’s ability to fight cancer. This therapy is preferable than the old technique because it provides long-term cancer protection, has fewer side effects, and treats a wider range of cancer. Cancer immunotherapy is used in different types of cancers such as melanoma, prostate cancer, breast cancer, colorectal cancer, lung cancer, head & neck cancer, and more. Cancer Immunother…

Melanoma is one of the malignant tumors whose incidence has increased more rapidly in recent years. By 2025, Spain estimates a total of 4,336 new cases in men and 5,072 new cases in women, so the total number is 9,408 estimated cases, according to SEOM's report The cancer figures in Spain 2025, which represents a significant increase over previous years. However, it should be noted that these data underestimate the actual condition of the pathol…

This alliance seeks to accelerate the arrival of patients with innovative treatments in haematological oncology

The oncology expert explains how the new therapies have allowed us to change the picture in the treatment of melanoma, even in advanced phases. However, she recalls that prevention and early detection remain the most effective way to avoid this oncological disease.